NRX Pharmaceuticals, Inc. - Common Stock — Balance Sheet (NASDAQ:NRXP) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 6.05 M32.73 M25.82 M7.32 M3.65 M12.96 M Total liabilities 3.28 M11.92 M18.41 M19.05 M26.87 M28.89 M Total equity 2.77 M20.81 M7.41 M-11.73 M-23.22 M-15.94 M Total liabilities & shareholders' equities 6.05 M32.73 M25.82 M7.32 M3.65 M12.96 M Total debt ———2.82 M6.58 M0 Net debt ———2.82 M5.13 M-7.8 M

News

NRx Pharmaceuticals: 'Sell' On ZYESAMI/NRX-101 Failures & Depression Market Uncertainty (NASDAQ:NRXP)

NRx Pharmaceuticals, Inc. (NRXP) Q1 2026 Earnings Call Transcript

NRx Pharmaceuticals, Inc. (NRXP) Reports Q1 Loss, Lags Revenue Estimates

NRx Pharmaceuticals Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earning

NRx Pharmaceuticals, Inc. (NRXP) Surpasses Q4 Earnings Estimates

NRx Pharmaceuticals, Inc. (NRXP) Shareholder/Analyst Call Prepared Remarks Transcript

NRx Pharmaceuticals receives FDA bioequivalence approval notice

NRx Pharmaceuticals receives FDA guidance on NRX-100 drug application

VTSAX vs. VTI: Which Vanguard Fund Should You Buy in 2026? - TipRanks.com

H.C. Wainwright raises NRx Pharmaceuticals stock price target to $45

NRx Pharmaceuticals appoints Joshua Brown as chief medical officer

NRx Builds Momentum From FDA Progress To Strategic Expansion - NRX Pharmaceuticals (NASDAQ:NRXP)